Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)

CUSIP: 761330109

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
104,661,494
Total 13F shares
34,965,934
Share change
+4,371,885
Total reported value
$1,250,026,502
Put/Call ratio
193%
Price per share
$35.75
Number of holders
115
Value change
+$169,498,952
Number of buys
77
Number of sells
26

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 761330109?
CUSIP 761330109 identifies RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Essex Woodlands Management, Inc.
13F
Company
4.4%
4,592,047
$126,511,000 30 Sep 2017
13F
JPMORGAN CHASE & CO
13F
Company
3.4%
3,546,267
$96,635,000 30 Sep 2017
13F
FRANKLIN RESOURCES INC
13F
Company
3.1%
3,288,778
$90,606,000 30 Sep 2017
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
2.2%
2,341,510
$64,508,000 30 Sep 2017
13F
BlackRock Finance, Inc.
13F
Company
2.1%
2,165,600
$59,662,000 30 Sep 2017
13F
ArrowMark Colorado Holdings LLC
13F
Company
2%
2,135,521
$58,834,000 30 Sep 2017
13F
Bank of New York Mellon Corp
13F
Company
1.9%
2,009,312
$55,356,000 30 Sep 2017
13F
Polar Capital LLP
13F
Company
1.4%
1,424,213
$39,237,000 30 Sep 2017
13F
VANGUARD GROUP INC
13F
Company
0.98%
1,024,335
$28,220,000 30 Sep 2017
13F
CANADA PENSION PLAN INVESTMENT BOARD
13F
Company
0.56%
582,900
$16,059,000 30 Sep 2017
13F
STATE STREET CORP
13F
Company
0.45%
466,097
$12,841,000 30 Sep 2017
13F
JENNISON ASSOCIATES LLC
13F
Company
0.36%
377,528
$10,401,000 30 Sep 2017
13F
NORTHERN TRUST CORP
13F
Company
0.28%
290,950
$8,015,000 30 Sep 2017
13F
FMR LLC
13F
Company
0.24%
249,200
$6,865,000 30 Sep 2017
13F
Rhenman & Partners Asset Management AB
13F
Company
0.24%
246,400
$6,788,000 30 Sep 2017
13F
WADDELL & REED FINANCIAL INC
13F
Company
0.2%
204,650
$5,638,000 30 Sep 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.19%
203,020
$5,593,000 30 Sep 2017
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.18%
184,880
$5,093,000 30 Sep 2017
13F
S.c.a. Candriam
13F
Individual
0.13%
136,000
$3,747,000 30 Sep 2017
13F
MORGAN STANLEY
13F
Company
0.12%
126,772
$3,493,000 30 Sep 2017
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.11%
117,258
$3,231,000 30 Sep 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.11%
114,476
$3,153,000 30 Sep 2017
13F
ESSEX INVESTMENT MANAGEMENT CO LLC
13F
Company
0.1%
104,928
$2,891,000 30 Sep 2017
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.08%
79,792
$2,198,000 30 Sep 2017
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.07%
78,059
$2,151,000 30 Sep 2017
13F
Vivo Capital, LLC
13F
Company
0.07%
77,373
$2,132,000 30 Sep 2017
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.07%
73,862
$2,035,000 30 Sep 2017
13F
Informed Momentum Co LLC
13F
Company
0.07%
72,518
$1,998,000 30 Sep 2017
13F
QS Investors, LLC
13F
Company
0.07%
71,866
$1,980,000 30 Sep 2017
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.06%
60,104
$1,656,000 30 Sep 2017
13F
UNITED SERVICES AUTOMOBILE ASSOCIATION
13F
Company
0.06%
58,966
$1,625,000 30 Sep 2017
13F
Allianz Asset Management GmbH
13F
Company
0.06%
57,822
$1,593,000 30 Sep 2017
13F
SUFFOLK CAPITAL MANAGEMENT LLC
13F
Company
0.05%
53,097
$1,463,000 30 Sep 2017
13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.
13F
Company
0.05%
53,008
$1,460,000 30 Sep 2017
13F
FEDERATED HERMES, INC.
13F
Company
0.05%
50,285
$1,385,000 30 Sep 2017
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.05%
50,000
$1,378,000 30 Sep 2017
13F
TEACHERS ADVISORS, LLC
13F
Company
0.04%
40,915
$1,127,000 30 Sep 2017
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.03%
36,522
$1,006,000 30 Sep 2017
13F
Swiss National Bank
13F
Company
0.03%
35,450
$977,000 30 Sep 2017
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.03%
35,047
$966,000 30 Sep 2017
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.03%
34,715
$956,000 30 Sep 2017
13F
ALPS ADVISORS INC
13F
Company
0.03%
30,351
$836,000 30 Sep 2017
13F
Nationwide Fund Advisors
13F
Company
0.03%
29,130
$803,000 30 Sep 2017
13F
ROYAL BANK OF CANADA
13F
Company
0.03%
27,321
$753,000 30 Sep 2017
13F
State of New Jersey Common Pension Fund D
13F
Company
0.02%
26,000
$716,000 30 Sep 2017
13F
RHUMBLINE ADVISERS
13F
Company
0.02%
25,603
$705,000 30 Sep 2017
13F
CREDIT SUISSE AG/
13F
Company
0.02%
24,373
$670,000 30 Sep 2017
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.02%
23,300
$642,000 30 Sep 2017
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.02%
22,984
$634,000 30 Sep 2017
13F
A.R.T. Advisors, LLC
13F
Company
0.02%
22,900
$630,000 30 Sep 2017
13F

Institutional Holders of Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) as of Q4 2017

As of 31 Dec 2017, Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) was held by 115 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,965,934 shares. The largest 10 holders included Essex Woodlands Management, Inc., WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, FRANKLIN RESOURCES INC, NovaQuest Capital Management, L.L.C., BlackRock Inc., Bank of New York Mellon Corp, ArrowMark Colorado Holdings LLC, Vanguard Group Inc, and MILLENNIUM MANAGEMENT LLC. This page lists 115 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2017 vs Q3 2017 Across Filers

Q3 2017 holders
84
Q4 2017 holders
115
Holder diff
31
Investor Q3 2017 Shares Q4 2017 Shares Share Diff Share Chg % Q3 2017 Value $ Q4 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.